Evidence map›Paper›PMID 29873578›Full record

ArticleHuman vaccines & immunotherapeutics2019

Immunogenicity and protective efficacy against

Ofir Schuster, Khandra T Sears, Girish Ramachandran, Fabien J Fuche, Brittany Curtis, Sharon M Tennant, Raphael Simon

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Vaccines for enteric diseases.Human vaccines & immunotherapeutics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ofir Schustera Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
Khandra T Searsa Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
Girish Ramachandrana Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
Fabien J Fuchea Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
Brittany Curtisa Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
Sharon M Tennanta Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
Raphael Simona Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
University of Maryland, Baltimore · USUnited States Food and Drug Administration · US

Funding

Shigella Live Vector-Based Multivalent VaccineU19AI109776 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2014 to 2018
$25.4M
NIAID NIH HHS U19 AI109776
6 · The paper itself

Abstract

Nontyphoidal

Indexed as

Immunogenicity, VaccineAnimalsAntibodies, BacterialFemaleFlagellinGlycoconjugatesImmunizationImmunoglobulin GMiceMice, Inbred BALB CPolysaccharides, BacterialSalmonella InfectionsSalmonella VaccinesSerogroupAntibodies, BacterialFlagellinGlycoconjugatesImmunoglobulin GPolysaccharides, BacterialSalmonella VaccinesconjugateflagellinGroup CO polysaccharidevaccine

Identifiers

PMID29873578
PMCPMC6663135
OpenAlexW2807316022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.